Hua-Guo Xu (Huaguo Xu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Systematic Review

Liver Metastases

Rheumatoid Arthritis Patients

Top Venues

Current oncology (Toronto, Ont.)

Journal of clinical medicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Can Chen, Jia Xu, Jie-Xin Zhang, Lin-Yuan Chen, Yu-Ang Wei, Wei-Ming Zhang, Peng-Fei Shao, Hua-Guo Xu
CD2AP is a potential prognostic biomarker of renal clear cell carcinoma. Cancer medicine 13 (4) (2024)
Jia Xu, Shu An, Ying Lu, Laisheng Li, Zhi-Qi Wu, Hua-Guo Xu
Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma. Cancer medicine (2023)
Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang, Hua-Guo Xu
Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis. Journal of clinical medicine 12 (3) (2023)
Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang, Hua-Guo Xu
Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis. Journal of clinical medicine 12 (3) (2023)
Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang, Hua-Guo Xu
Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis. Journal of clinical medicine 12 (3) (2023)
Jun Zhou, Zhi-Qi Wu, Tengfei Qiao, Hua-Guo Xu
Development of Laboratory Parameters-Based Formulas in Predicting Short Outcomes for Adult Hemophagocytic Lymphohistiocytosis Patients with Different Underlying Diseases. Journal of clinical immunology 42 (5) (2022)
Can Chen, Rui-Xia Yang, Jie-Xin Zhang, Hua-Guo Xu
Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte-associated genes. Cancer medicine 11 (19) (2022)
Can Chen, Lin-Yuan Chen, Jie-Xin Zhang, Hua-Guo Xu
5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma. Current oncology (Toronto, Ont.) 30 (1) (2022)
Dong-Ze Ji, Xiao-Yu Pang, Dan-Ting Shen, Shu-Na Liu, Hemant Goyal, Hua-Guo Xu
Global prevalence of occult hepatitis B: A systematic review and meta-analysis. Journal of viral hepatitis 29 (5) (2022)
Can Chen, Lin-Yuan Chen, Jie-Xin Zhang, Hua-Guo Xu
5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma. Current oncology (Toronto, Ont.) 30 (1) (2022)
Can Chen, Lin-Yuan Chen, Jie-Xin Zhang, Hua-Guo Xu
5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma. Current oncology (Toronto, Ont.) 30 (1) (2022)
Can Chen, Lin-Yuan Chen, Jie-Xin Zhang, Hua-Guo Xu
5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma. Current oncology (Toronto, Ont.) 30 (1) (2022)
Can Chen, Lin-Yuan Chen, Jie-Xin Zhang, Hua-Guo Xu
5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma. Current oncology (Toronto, Ont.) 30 (1) (2022)
Hua-Guo Xu, Meng Tian, Shi-Yang Pan
Clinical utility of procalcitonin and its association with pathogenic microorganisms. Critical reviews in clinical laboratory sciences (2021)
Dan-Ting Shen, Pei-Chun Han, Dong-Ze Ji, Hai-Yan Chen, Wei-Dong Cao, Hemant Goyal, Hua-Guo Xu
Epidemiology estimates of hepatitis D in individuals co-infected with human immunodeficiency virus and hepatitis B virus, 2002-2018: A systematic review and meta-analysis. Journal of viral hepatitis 28 (7) (2021)
Lin-Yuan Chen, Xiao-Yu Pang, Hemant Goyal, Rui-Xia Yang, Hua-Guo Xu
Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis. Gut pathogens 13 (1) (2021)
Can Chen, Rui-Xia Yang, Hua-Guo Xu
STING and liver disease. Journal of gastroenterology 56 (8) (2021)
Jun Zhou, Jing Zhou, Zhi-Qi Wu, Hemant Goyal, Hua-Guo Xu
A novel prognostic model for adult patients with Hemophagocytic Lymphohistiocytosis. Orphanet journal of rare diseases 15 (1) (2020)
Jun Zhou, Jing Zhou, Dan-Ting Shen, Hemant Goyal, Zhi-Qi Wu, Hua-Guo Xu
Development and validation of the prognostic value of ferritin in adult patients with Hemophagocytic Lymphohistiocytosis. Orphanet journal of rare diseases 15 (1) (2020)
Dan-Ting Shen, Hemant Goyal, Hua-Guo Xu
Differences in delta virus hepatitis diagnosis methods and its effect on the hepatitis D prevalence. Gut 69 (10) (2019)
Erfu Xie, Wei Zhang, Hua-Guo Xu, Yun Ling, Qiaodi Zhang, Shiyang Pan
Correction of serum NSE reference intervals includes the unidentified hemolysis sample: 1-year data analysis from healthcare individuals. Journal of clinical laboratory analysis 33 (9) (2019)
Dan-Ting Shen, Dong-Ze Ji, Hai-Yan Chen, Hemant Goyal, Shiyang Pan, Hua-Guo Xu
Hepatitis D: not a rare disease anymore: global update for 2017-2018. Gut 69 (4) (2019)
Xiaoting Chen, Jia Wang, Wei Zhang, Erfu Xie, Bingfeng Zhang, Hua-Guo Xu
Failure of internal quality control in detecting significant reagent lot shift in serum creatinine measurement. Journal of clinical laboratory analysis 33 (9) (2019)
Zhi-Qi Wu, Hua-Guo Xu
Comparison of two commercial quality control sera for adrenocorticotropin (ACTH) used in Elecsys® immunoassay system. Journal of clinical laboratory analysis 33 (1) (2018)
Hai-Yan Chen, Dan-Ting Shen, Dong-Ze Ji, Pei-Chun Han, Wei-Ming Zhang, Jian-Feng Ma, Wen-Sen Chen, Hemant Goyal, Shiyang Pan, Hua-Guo Xu
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut 68 (3) (2018)